NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 | ₹25.32 |
What is the latest Earnings Per Share (EPS) of NATCO PHARMA ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹77.56 |
Mar2023 | ₹39.19 |
Mar2022 | ₹9.32 |
Mar2021 | ₹24.16 |
Mar2020 | ₹25.32 |
How is Earnings Per Share (EPS) of NATCO PHARMA Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹77.56 | 97.91 | |
Mar2023 | ₹39.19 | 320.49 | |
Mar2022 | ₹9.32 | -61.42 | |
Mar2021 | ₹24.16 | -4.58 | |
Mar2020 | ₹25.32 | - |
Compare Earnings Per Share (EPS) of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,823.5 Cr | 4.5% | 7.1% | -11.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 4.5% |
7.1% |
-11.6% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses